Vaccines Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Vaccines stocks.

Vaccines Stocks Recent News

Date Stock Title
Jun 1 BNTX BioNTech/ Genmab lung cancer therapy improves survival with Keytruda
Jun 1 BNTX Investigational Acasunlimab (DuoBody® -PD-L1x4-1BB) in Combination with Pembrolizumab Demonstrates Meaningful Clinical Activity in Phase 2 Trial in Patients with Previously Treated Metastatic Non-small Cell Lung Cancer (mNSCLC)
Jun 1 MRNA Moderna, Inc. (MRNA) Bernstein's 40th Annual Strategic Decisions Conference (Transcript)
May 31 MRNA Moderna Scores FDA Approval For Its Second Product - Respiratory Syncytial Virus Vaccine
May 31 MRNA Moderna Gets FDA Approval For Respiratory Syncytial Virus Vaccine for Seniors
May 31 MRNA Top Midday Stories: SQM, Codelco to Mine Lithium; Moderna Gets Approval for RSV Vaccine; Tesla Recalls Over 100,000 Cars; Icahn Amasses Stake in Caesars
May 31 MRNA Moderna Looks for Boost From Newly Approved RSV Shot
May 31 MRNA Moderna Wins FDA Approval For Second-Ever Product; Why Its RSV Vaccine Could Dominate Pfizer, GSK
May 31 MRNA Moderna wins FDA approval for RSV vaccine
May 31 MRNA Moderna Receives U.S. FDA Approval for RSV Vaccine mRESVIA(R)
May 31 BNTX NHS launches personalised mRNA cancer vaccines trial
May 30 MRNA Why Moderna Stock Is Sinking This Week
May 30 MRNA The U.S. Is Close To Bankrolling Moderna's Bird Flu Vaccine As Third Dairy Worker Tests Positive
May 30 INO Russell 3000: Inovio, Ocugen among healthcare additions; Assertio, Ginkgo Bioworks among deletions
May 30 MRNA Third human bird flu case found in U.S.
May 30 MRNA The Zacks Analyst Blog Highlights NVIDIA, Constellation Energy, Micron Technology, Moderna and Qualcomm
May 30 NVAX Novavax to Participate in 2024 Jefferies Global Healthcare Conference
May 30 MRNA Option Trade On Volatile Moderna Could Return 28% By Mid-July
May 30 MRNA Moderna nearing deal to win U.S. funding for bird flu vaccine trial: FT
May 30 BNTX BioNTech and CEPI expand deal to boost Africa’s vaccine capabilities
Vaccines

A vaccine is a biological preparation that provides active acquired immunity to a particular disease. A vaccine typically contains an agent that resembles a disease-causing microorganism and is often made from weakened or killed forms of the microbe, its toxins, or one of its surface proteins. The agent stimulates the body's immune system to recognize the agent as a threat, destroy it, and to further recognize and destroy any of the microorganisms associated with that agent that it may encounter in the future. Vaccines can be prophylactic (example: to prevent or ameliorate the effects of a future infection by a natural or "wild" pathogen), or therapeutic (e.g., vaccines against cancer are being investigated).The administration of vaccines is called vaccination. Vaccination is the most effective method of preventing infectious diseases; widespread immunity due to vaccination is largely responsible for the worldwide eradication of smallpox and the restriction of diseases such as polio, measles, and tetanus from much of the world.
The effectiveness of vaccination has been widely studied and verified; for example, vaccines that have proven effective include the influenza vaccine, the HPV vaccine, and the chicken pox vaccine. The World Health Organization (WHO) reports that licensed vaccines are currently available for twenty-five different preventable infections.The terms vaccine and vaccination are derived from Variolae vaccinae (smallpox of the cow), the term devised by Edward Jenner to denote cowpox. He used it in 1798 in the long title of his Inquiry into the Variolae vaccinae known as the Cow Pox, in which he described the protective effect of cowpox against smallpox. In 1881, to honor Jenner, Louis Pasteur proposed that the terms should be extended to cover the new protective inoculations then being developed.

Browse All Tags